IBDEI07Z ; ; 13-FEB-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 13, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10480,1,3,0)
 ;;=3^Nystagmus Central Positions
 ;;^UTILITY(U,$J,358.3,10480,1,4,0)
 ;;=4^386.2
 ;;^UTILITY(U,$J,358.3,10480,2)
 ;;=^269484
 ;;^UTILITY(U,$J,358.3,10481,0)
 ;;=434.91^^72^692^34
 ;;^UTILITY(U,$J,358.3,10481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10481,1,3,0)
 ;;=3^Embolism w/ Infarct
 ;;^UTILITY(U,$J,358.3,10481,1,4,0)
 ;;=4^434.91
 ;;^UTILITY(U,$J,358.3,10481,2)
 ;;=^295738
 ;;^UTILITY(U,$J,358.3,10482,0)
 ;;=435.9^^72^692^122
 ;;^UTILITY(U,$J,358.3,10482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10482,1,3,0)
 ;;=3^Transient Ischemic Attack
 ;;^UTILITY(U,$J,358.3,10482,1,4,0)
 ;;=4^435.9
 ;;^UTILITY(U,$J,358.3,10482,2)
 ;;=^21635
 ;;^UTILITY(U,$J,358.3,10483,0)
 ;;=436.^^72^692^16
 ;;^UTILITY(U,$J,358.3,10483,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10483,1,3,0)
 ;;=3^CVA
 ;;^UTILITY(U,$J,358.3,10483,1,4,0)
 ;;=4^436.
 ;;^UTILITY(U,$J,358.3,10483,2)
 ;;=^2710
 ;;^UTILITY(U,$J,358.3,10484,0)
 ;;=437.3^^72^692^8
 ;;^UTILITY(U,$J,358.3,10484,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10484,1,3,0)
 ;;=3^Aneurysm,Brain,Nonruptured
 ;;^UTILITY(U,$J,358.3,10484,1,4,0)
 ;;=4^437.3
 ;;^UTILITY(U,$J,358.3,10484,2)
 ;;=^269755
 ;;^UTILITY(U,$J,358.3,10485,0)
 ;;=438.7^^72^692^30
 ;;^UTILITY(U,$J,358.3,10485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10485,1,3,0)
 ;;=3^Disturbances of Vision
 ;;^UTILITY(U,$J,358.3,10485,1,4,0)
 ;;=4^438.7
 ;;^UTILITY(U,$J,358.3,10485,2)
 ;;=^328504
 ;;^UTILITY(U,$J,358.3,10486,0)
 ;;=728.85^^72^692^68
 ;;^UTILITY(U,$J,358.3,10486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10486,1,3,0)
 ;;=3^Muscle Spasm
 ;;^UTILITY(U,$J,358.3,10486,1,4,0)
 ;;=4^728.85
 ;;^UTILITY(U,$J,358.3,10486,2)
 ;;=^112558
 ;;^UTILITY(U,$J,358.3,10487,0)
 ;;=729.1^^72^692^36
 ;;^UTILITY(U,$J,358.3,10487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10487,1,3,0)
 ;;=3^Fibromylagia
 ;;^UTILITY(U,$J,358.3,10487,1,4,0)
 ;;=4^729.1
 ;;^UTILITY(U,$J,358.3,10487,2)
 ;;=^80160
 ;;^UTILITY(U,$J,358.3,10488,0)
 ;;=742.3^^72^692^53
 ;;^UTILITY(U,$J,358.3,10488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10488,1,3,0)
 ;;=3^Hydrocephalus,Congenital
 ;;^UTILITY(U,$J,358.3,10488,1,4,0)
 ;;=4^742.3
 ;;^UTILITY(U,$J,358.3,10488,2)
 ;;=^59563
 ;;^UTILITY(U,$J,358.3,10489,0)
 ;;=743.57^^72^692^85
 ;;^UTILITY(U,$J,358.3,10489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10489,1,3,0)
 ;;=3^Optic Disc Coloboma,Congenital
 ;;^UTILITY(U,$J,358.3,10489,1,4,0)
 ;;=4^743.57
 ;;^UTILITY(U,$J,358.3,10489,2)
 ;;=^272837
 ;;^UTILITY(U,$J,358.3,10490,0)
 ;;=747.81^^72^692^2
 ;;^UTILITY(U,$J,358.3,10490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10490,1,3,0)
 ;;=3^AVM,Brain,Congenital
 ;;^UTILITY(U,$J,358.3,10490,1,4,0)
 ;;=4^747.81
 ;;^UTILITY(U,$J,358.3,10490,2)
 ;;=^272916
 ;;^UTILITY(U,$J,358.3,10491,0)
 ;;=780.1^^72^692^44
 ;;^UTILITY(U,$J,358.3,10491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10491,1,3,0)
 ;;=3^Hallucinations,Auditory
 ;;^UTILITY(U,$J,358.3,10491,1,4,0)
 ;;=4^780.1
 ;;^UTILITY(U,$J,358.3,10491,2)
 ;;=^53738
 ;;^UTILITY(U,$J,358.3,10492,0)
 ;;=780.2^^72^692^112
 ;;^UTILITY(U,$J,358.3,10492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10492,1,3,0)
 ;;=3^Syncope
 ;;^UTILITY(U,$J,358.3,10492,1,4,0)
 ;;=4^780.2
 ;;^UTILITY(U,$J,358.3,10492,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,10493,0)
 ;;=780.39^^72^692^110
 ;;^UTILITY(U,$J,358.3,10493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10493,1,3,0)
 ;;=3^Seizure Disorder
 ;;^UTILITY(U,$J,358.3,10493,1,4,0)
 ;;=4^780.39
 ;;^UTILITY(U,$J,358.3,10493,2)
 ;;=^28162
 ;;^UTILITY(U,$J,358.3,10494,0)
 ;;=780.4^^72^692^32
 ;;^UTILITY(U,$J,358.3,10494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10494,1,3,0)
 ;;=3^Dizziness
 ;;^UTILITY(U,$J,358.3,10494,1,4,0)
 ;;=4^780.4
 ;;^UTILITY(U,$J,358.3,10494,2)
 ;;=^35946
 ;;^UTILITY(U,$J,358.3,10495,0)
 ;;=780.71^^72^692^22
 ;;^UTILITY(U,$J,358.3,10495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10495,1,3,0)
 ;;=3^Chronic Fatigue Syndrome
 ;;^UTILITY(U,$J,358.3,10495,1,4,0)
 ;;=4^780.71
 ;;^UTILITY(U,$J,358.3,10495,2)
 ;;=^304659
 ;;^UTILITY(U,$J,358.3,10496,0)
 ;;=795.79^^72^692^1
 ;;^UTILITY(U,$J,358.3,10496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10496,1,3,0)
 ;;=3^ACLA/APLA
 ;;^UTILITY(U,$J,358.3,10496,1,4,0)
 ;;=4^795.79
 ;;^UTILITY(U,$J,358.3,10496,2)
 ;;=^303352
 ;;^UTILITY(U,$J,358.3,10497,0)
 ;;=854.01^^72^692^120
 ;;^UTILITY(U,$J,358.3,10497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10497,1,3,0)
 ;;=3^TBI-Open Wound,No LOC
 ;;^UTILITY(U,$J,358.3,10497,1,4,0)
 ;;=4^854.01
 ;;^UTILITY(U,$J,358.3,10497,2)
 ;;=^274712
 ;;^UTILITY(U,$J,358.3,10498,0)
 ;;=854.02^^72^692^118
 ;;^UTILITY(U,$J,358.3,10498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10498,1,3,0)
 ;;=3^TBI-Open Wound,LOC < 1hr
 ;;^UTILITY(U,$J,358.3,10498,1,4,0)
 ;;=4^854.02
 ;;^UTILITY(U,$J,358.3,10498,2)
 ;;=^274713
 ;;^UTILITY(U,$J,358.3,10499,0)
 ;;=854.03^^72^692^117
 ;;^UTILITY(U,$J,358.3,10499,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10499,1,3,0)
 ;;=3^TBI-Open Wound,LOC 1-24hr
 ;;^UTILITY(U,$J,358.3,10499,1,4,0)
 ;;=4^854.03
 ;;^UTILITY(U,$J,358.3,10499,2)
 ;;=^274714
 ;;^UTILITY(U,$J,358.3,10500,0)
 ;;=854.04^^72^692^119
 ;;^UTILITY(U,$J,358.3,10500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10500,1,3,0)
 ;;=3^TBI-Open Wound,LOC > 24hr
 ;;^UTILITY(U,$J,358.3,10500,1,4,0)
 ;;=4^854.04
 ;;^UTILITY(U,$J,358.3,10500,2)
 ;;=^274715
 ;;^UTILITY(U,$J,358.3,10501,0)
 ;;=854.11^^72^692^114
 ;;^UTILITY(U,$J,358.3,10501,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10501,1,3,0)
 ;;=3^TBI-Closed Wound,No LOC
 ;;^UTILITY(U,$J,358.3,10501,1,4,0)
 ;;=4^854.11
 ;;^UTILITY(U,$J,358.3,10501,2)
 ;;=^274721
 ;;^UTILITY(U,$J,358.3,10502,0)
 ;;=854.12^^72^692^113
 ;;^UTILITY(U,$J,358.3,10502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10502,1,3,0)
 ;;=3^TBI-Closed Wound,LOC < 1hr
 ;;^UTILITY(U,$J,358.3,10502,1,4,0)
 ;;=4^854.12
 ;;^UTILITY(U,$J,358.3,10502,2)
 ;;=^274722
 ;;^UTILITY(U,$J,358.3,10503,0)
 ;;=854.13^^72^692^115
 ;;^UTILITY(U,$J,358.3,10503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10503,1,3,0)
 ;;=3^TBI-Closed,LOC 1-24hr
 ;;^UTILITY(U,$J,358.3,10503,1,4,0)
 ;;=4^854.13
 ;;^UTILITY(U,$J,358.3,10503,2)
 ;;=^274723
 ;;^UTILITY(U,$J,358.3,10504,0)
 ;;=854.14^^72^692^116
 ;;^UTILITY(U,$J,358.3,10504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10504,1,3,0)
 ;;=3^TBI-Closed,LOC > 24hr
 ;;^UTILITY(U,$J,358.3,10504,1,4,0)
 ;;=4^854.14
 ;;^UTILITY(U,$J,358.3,10504,2)
 ;;=^274724
 ;;^UTILITY(U,$J,358.3,10505,0)
 ;;=908.3^^72^692^17
 ;;^UTILITY(U,$J,358.3,10505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10505,1,3,0)
 ;;=3^Carotid Cavernous Fistula,Late Effect
 ;;^UTILITY(U,$J,358.3,10505,1,4,0)
 ;;=4^908.3
 ;;^UTILITY(U,$J,358.3,10505,2)
 ;;=^275249
 ;;^UTILITY(U,$J,358.3,10506,0)
 ;;=368.2^^72^693^24
 ;;^UTILITY(U,$J,358.3,10506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10506,1,3,0)
 ;;=3^Diplopia
 ;;^UTILITY(U,$J,358.3,10506,1,4,0)
 ;;=4^368.2
 ;;^UTILITY(U,$J,358.3,10506,2)
 ;;=^35208
 ;;^UTILITY(U,$J,358.3,10507,0)
 ;;=695.3^^72^693^2
 ;;^UTILITY(U,$J,358.3,10507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10507,1,3,0)
 ;;=3^Acne Rosacea
 ;;^UTILITY(U,$J,358.3,10507,1,4,0)
 ;;=4^695.3
 ;;^UTILITY(U,$J,358.3,10507,2)
 ;;=Acne Rosacea^107114
 ;;^UTILITY(U,$J,358.3,10508,0)
 ;;=250.00^^72^693^22
 ;;^UTILITY(U,$J,358.3,10508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10508,1,3,0)
 ;;=3^DM type II w/o Eye Disease
 ;;^UTILITY(U,$J,358.3,10508,1,4,0)
 ;;=4^250.00
 ;;^UTILITY(U,$J,358.3,10508,2)
 ;;=DM type II w/o Eye Disease^33605
 ;;^UTILITY(U,$J,358.3,10509,0)
 ;;=346.90^^72^693^41
 ;;^UTILITY(U,$J,358.3,10509,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10509,1,3,0)
 ;;=3^Headache,Migraine-Not Intractable
 ;;^UTILITY(U,$J,358.3,10509,1,4,0)
 ;;=4^346.90
 ;;^UTILITY(U,$J,358.3,10509,2)
 ;;=Migraine without Intract^293880
 ;;^UTILITY(U,$J,358.3,10510,0)
 ;;=376.30^^72^693^30
 ;;^UTILITY(U,$J,358.3,10510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10510,1,3,0)
 ;;=3^Exophthalmos,NOS
 ;;^UTILITY(U,$J,358.3,10510,1,4,0)
 ;;=4^376.30
 ;;^UTILITY(U,$J,358.3,10510,2)
 ;;=Exophthalmos NOS^43683
 ;;^UTILITY(U,$J,358.3,10511,0)
 ;;=368.8^^72^693^7
 ;;^UTILITY(U,$J,358.3,10511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10511,1,3,0)
 ;;=3^Blurred Vision
 ;;^UTILITY(U,$J,358.3,10511,1,4,0)
 ;;=4^368.8
 ;;^UTILITY(U,$J,358.3,10511,2)
 ;;=Blurred Vision^88172
 ;;^UTILITY(U,$J,358.3,10512,0)
 ;;=362.34^^72^693^5
 ;;^UTILITY(U,$J,358.3,10512,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10512,1,3,0)
 ;;=3^Amaurosis Fugax
 ;;^UTILITY(U,$J,358.3,10512,1,4,0)
 ;;=4^362.34
 ;;^UTILITY(U,$J,358.3,10512,2)
 ;;=^268622
 ;;^UTILITY(U,$J,358.3,10513,0)
 ;;=368.13^^72^693^87
 ;;^UTILITY(U,$J,358.3,10513,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10513,1,3,0)
 ;;=3^Photophobia
 ;;^UTILITY(U,$J,358.3,10513,1,4,0)
 ;;=4^368.13
 ;;^UTILITY(U,$J,358.3,10513,2)
 ;;=^126851
 ;;^UTILITY(U,$J,358.3,10514,0)
 ;;=368.40^^72^693^112
 ;;^UTILITY(U,$J,358.3,10514,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10514,1,3,0)
 ;;=3^Vis Field Defect
 ;;^UTILITY(U,$J,358.3,10514,1,4,0)
 ;;=4^368.40
 ;;^UTILITY(U,$J,358.3,10514,2)
 ;;=^126859
 ;;^UTILITY(U,$J,358.3,10515,0)
 ;;=369.4^^72^693^58
 ;;^UTILITY(U,$J,358.3,10515,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10515,1,3,0)
 ;;=3^Legally Blind,USA Definition
 ;;^UTILITY(U,$J,358.3,10515,1,4,0)
 ;;=4^369.4
 ;;^UTILITY(U,$J,358.3,10515,2)
 ;;=Legal Blindness^268887
 ;;^UTILITY(U,$J,358.3,10516,0)
 ;;=250.01^^72^693^21
 ;;^UTILITY(U,$J,358.3,10516,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10516,1,3,0)
 ;;=3^DM Type I w/o Eye Disease
 ;;^UTILITY(U,$J,358.3,10516,1,4,0)
 ;;=4^250.01
 ;;^UTILITY(U,$J,358.3,10516,2)
 ;;=Diabetes Mellitus Type I^33586
 ;;^UTILITY(U,$J,358.3,10517,0)
 ;;=V08.^^72^693^40
 ;;^UTILITY(U,$J,358.3,10517,1,0)
 ;;=^358.31IA^4^2
